Preview

PDF 9[1].3(000).pdf | Download (90kB) Available under University of Tasmania Standard License. | Preview

Abstract

This paper reports the results of an empirical study of
the Australian medical biotechnology industry, involving
surveys and interviews with participants in research
institutions, companies and diagnostic facilities.
Despite ongoing concerns about the impact of gene and
research tool patents on downstream research and
development, this study reveals evidence of liberal
licensing practices associated with some essential or
foundational inventions within the Australian industry.
However, there are also significant challenges, including
negotiating difficulties, restrictive licence terms, refusals to license and stacking royalties. Hence some consideration of the options for law reform is warranted.

Item Type:	Article
Authors/Creators:	Nicol, D and Nielsen, JL
Journal or Publication Title:	European Intellectual Property Review
ISSN:	0142-0461
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page